Skip to main content
Gary Hunninghake, MD, Pulmonology, Boston, MA

Gary Matthew Hunninghake MD MPH

Critical Care Medicine, Interstitial Lung Diseases


Associate Professor, Medicine-Brigham & Women's Hospital, Harvard Med Sch

Join to View Full Profile
  • 55 Fruit St# BulBoston, MA 02114

  • Phone+1 617-726-3734

  • Fax+1 857-307-0899

Dr. Hunninghake is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical School
    Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2007
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1999 - 2002
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2003 - 2026
  • VA State Medical License
    VA State Medical License 1999 - 2004
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Journal Articles

  • Malaria and the Development of Pulmonary Fibrosis  
    Ezra R Miller, Gary M Hunninghake, The European Respiratory Journal

Other

Press Mentions

  • Implanted Lung Valves Show Promise in Some Emphysema Patients
    Implanted Lung Valves Show Promise in Some Emphysema PatientsDecember 9th, 2015
  • IPF Survival Better with Novel Drug?
    IPF Survival Better with Novel Drug?May 18th, 2014
  • Nintedanib Slows IPF Progression
    Nintedanib Slows IPF ProgressionMay 18th, 2014

Grant Support

  • Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung AbnormalitiesBRIGHAM AND WOMEN'S HOSPITAL2017–2027
  • Clinical Genetics and Screening for Pulmonary FibrosisBRIGHAM AND WOMEN'S HOSPITAL2016–2026
  • Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.BRIGHAM AND WOMEN'S HOSPITAL2013–2025
  • Fine-Mapping Association Analysis Of Total IGE On Chr. 20p12 In Costa RicansNational Heart, Lung, And Blood Institute2008–2011
  • The Genetic Epidemiology Of Asthma In Costa RicaNational Heart, Lung, And Blood Institute2006–2007

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: